 | • レポートコード：GIR-2104Z07643 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、炎症性腸疾患治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。炎症性腸疾患治療薬の種類別市場規模（抗炎症生物製剤、非ステロイド性抗炎症薬（NSAID）、コルチコステロイド）、用途別市場規模（病院用、家庭用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・炎症性腸疾患治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbvie、Johnson & Johnson、GlaxoSmithKline、Merck、Novartis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：抗炎症生物製剤、非ステロイド性抗炎症薬（NSAID）、コルチコステロイド ・用途別分析2016年-2026年：病院用、家庭用 ・炎症性腸疾患治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・炎症性腸疾患治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・炎症性腸疾患治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・炎症性腸疾患治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・炎症性腸疾患治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Inflammatory Bowel Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Inflammatory Bowel Disease Therapeutics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Inflammatory Bowel Disease Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Inflammatory Bowel Disease Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Corticosteroids
Market segment by Application, can be divided into
Hospital Use
Home Use
Market segment by players, this report covers
Abbvie
Johnson & Johnson
GlaxoSmithKline
Merck
Novartis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Inflammatory Bowel Disease Therapeutics
1.2 Classification of Inflammatory Bowel Disease Therapeutics by Type
1.2.1 Overview: Global Inflammatory Bowel Disease Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type in 2020
1.2.3 Anti-inflammatory Biologics
1.2.4 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
1.2.5 Corticosteroids
1.3 Global Inflammatory Bowel Disease Therapeutics Market by Application
1.3.1 Overview: Global Inflammatory Bowel Disease Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Use
1.3.3 Home Use
1.4 Global Inflammatory Bowel Disease Therapeutics Market Size & Forecast
1.5 Global Inflammatory Bowel Disease Therapeutics Market Size and Forecast by Region
1.5.1 Global Inflammatory Bowel Disease Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Inflammatory Bowel Disease Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Inflammatory Bowel Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Inflammatory Bowel Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Inflammatory Bowel Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Inflammatory Bowel Disease Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Inflammatory Bowel Disease Therapeutics Market Drivers
1.6.2 Inflammatory Bowel Disease Therapeutics Market Restraints
1.6.3 Inflammatory Bowel Disease Therapeutics Trends Analysis
2 Company Profiles
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business
2.1.3 Abbvie Inflammatory Bowel Disease Therapeutics Product and Solutions
2.1.4 Abbvie Inflammatory Bowel Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbvie Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product and Solutions
2.2.4 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product and Solutions
2.3.4 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Inflammatory Bowel Disease Therapeutics Product and Solutions
2.4.4 Merck Inflammatory Bowel Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Inflammatory Bowel Disease Therapeutics Product and Solutions
2.5.4 Novartis Inflammatory Bowel Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Novartis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Inflammatory Bowel Disease Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Inflammatory Bowel Disease Therapeutics Players Market Share
3.2.2 Top 10 Inflammatory Bowel Disease Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Inflammatory Bowel Disease Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Inflammatory Bowel Disease Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Inflammatory Bowel Disease Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Inflammatory Bowel Disease Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Inflammatory Bowel Disease Therapeutics Revenue by Type (2016-2026)
6.2 North America Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2026)
6.3 North America Inflammatory Bowel Disease Therapeutics Market Size by Country
6.3.1 North America Inflammatory Bowel Disease Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Inflammatory Bowel Disease Therapeutics Revenue by Type (2016-2026)
7.2 Europe Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2026)
7.3 Europe Inflammatory Bowel Disease Therapeutics Market Size by Country
7.3.1 Europe Inflammatory Bowel Disease Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region
8.3.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue by Region (2016-2026)
8.3.2 China Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Inflammatory Bowel Disease Therapeutics Revenue by Type (2016-2026)
9.2 South America Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2026)
9.3 South America Inflammatory Bowel Disease Therapeutics Market Size by Country
9.3.1 South America Inflammatory Bowel Disease Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Inflammatory Bowel Disease Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country
10.3.1 Middle East & Africa Inflammatory Bowel Disease Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Inflammatory Bowel Disease Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Inflammatory Bowel Disease Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Inflammatory Bowel Disease Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Inflammatory Bowel Disease Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Inflammatory Bowel Disease Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Abbvie Corporate Information, Head Office, and Major Competitors
Table 7. Abbvie Major Business
Table 8. Abbvie Inflammatory Bowel Disease Therapeutics Product and Solutions
Table 9. Abbvie Inflammatory Bowel Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product and Solutions
Table 13. Johnson & Johnson Inflammatory Bowel Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product and Solutions
Table 17. GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Inflammatory Bowel Disease Therapeutics Product and Solutions
Table 21. Merck Inflammatory Bowel Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Novartis Corporate Information, Head Office, and Major Competitors
Table 23. Novartis Major Business
Table 24. Novartis Inflammatory Bowel Disease Therapeutics Product and Solutions
Table 25. Novartis Inflammatory Bowel Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Inflammatory Bowel Disease Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 27. Global Inflammatory Bowel Disease Therapeutics Revenue Share by Players (2019-2021)
Table 28. Breakdown of Inflammatory Bowel Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Inflammatory Bowel Disease Therapeutics Players Head Office, Products and Services Provided
Table 30. Inflammatory Bowel Disease Therapeutics Mergers & Acquisitions in the Past Five Years
Table 31. Inflammatory Bowel Disease Therapeutics New Entrants and Expansion Plans
Table 32. Global Inflammatory Bowel Disease Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 33. Global Inflammatory Bowel Disease Therapeutics Revenue Share by Type (2016-2021)
Table 34. Global Inflammatory Bowel Disease Therapeutics Revenue Forecast by Type (2021-2026)
Table 35. Global Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2021)
Table 36. Global Inflammatory Bowel Disease Therapeutics Revenue Forecast by Application (2021-2026)
Table 37. North America Inflammatory Bowel Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Inflammatory Bowel Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Inflammatory Bowel Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Inflammatory Bowel Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Inflammatory Bowel Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Inflammatory Bowel Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Inflammatory Bowel Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Inflammatory Bowel Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Inflammatory Bowel Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Inflammatory Bowel Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Inflammatory Bowel Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Inflammatory Bowel Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Inflammatory Bowel Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Inflammatory Bowel Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Inflammatory Bowel Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Inflammatory Bowel Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Inflammatory Bowel Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Inflammatory Bowel Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Inflammatory Bowel Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Inflammatory Bowel Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Inflammatory Bowel Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Inflammatory Bowel Disease Therapeutics Picture
Figure 2. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type in 2020
Figure 3. Anti-inflammatory Biologics
Figure 4. Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Figure 5. Corticosteroids
Figure 6. Inflammatory Bowel Disease Therapeutics Revenue Market Share by Application in 2020
Figure 7. Hospital Use Picture
Figure 8. Home Use Picture
Figure 9. Global Inflammatory Bowel Disease Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Inflammatory Bowel Disease Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Region (2016-2026)
Figure 12. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Region in 2020
Figure 13. North America Inflammatory Bowel Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Inflammatory Bowel Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Inflammatory Bowel Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Inflammatory Bowel Disease Therapeutics Market Drivers
Figure 18. Inflammatory Bowel Disease Therapeutics Market Restraints
Figure 19. Inflammatory Bowel Disease Therapeutics Market Trends
Figure 20. Abbvie Recent Developments and Future Plans
Figure 21. Johnson & Johnson Recent Developments and Future Plans
Figure 22. GlaxoSmithKline Recent Developments and Future Plans
Figure 23. Merck Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 26. Global Inflammatory Bowel Disease Therapeutics Revenue Share by Players in 2020
Figure 27. Inflammatory Bowel Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 28. Global Top 3 Players Inflammatory Bowel Disease Therapeutics Revenue Market Share in 2020
Figure 29. Global Top 10 Players Inflammatory Bowel Disease Therapeutics Revenue Market Share in 2020
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 31. Global Inflammatory Bowel Disease Therapeutics Revenue Share by Type in 2020
Figure 32. Global Inflammatory Bowel Disease Therapeutics Market Share Forecast by Type (2021-2026)
Figure 33. Global Inflammatory Bowel Disease Therapeutics Revenue Share by Application in 2020
Figure 34. Global Inflammatory Bowel Disease Therapeutics Market Share Forecast by Application (2021-2026)
Figure 35. North America Inflammatory Bowel Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 36. North America Inflammatory Bowel Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 37. North America Inflammatory Bowel Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 38. United States Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Canada Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Mexico Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Europe Inflammatory Bowel Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 42. Europe Inflammatory Bowel Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 43. Europe Inflammatory Bowel Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 44. Germany Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. France Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. United Kingdom Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Russia Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Italy Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Inflammatory Bowel Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 50. Asia-Pacific Inflammatory Bowel Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 51. Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue Market Share by Region (2016-2026)
Figure 52. China Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Japan Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South Korea Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. India Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Southeast Asia Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Australia Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South America Inflammatory Bowel Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 59. South America Inflammatory Bowel Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 60. South America Inflammatory Bowel Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 61. Brazil Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Argentina Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Middle East and Africa Inflammatory Bowel Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 64. Middle East and Africa Inflammatory Bowel Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 65. Middle East and Africa Inflammatory Bowel Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 66. Turkey Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Saudi Arabia Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. UAE Inflammatory Bowel Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source
世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Therapeutics Market The global Inflammatory Bowel Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…- 世界の炎症性腸疾患市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…
- 世界の炎症性腸疾患緩和市場規模・現状・予測（2021年-2027年） Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative disease (UC), are proposed to result from an inappropriate immune response to the gut microbes in a genetically susceptible host. Market Analysis and Insights: Global Inflammatory Bowel Disease Relief Market The global …
- 世界の炎症性腸疾患（IBD）治療市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…
- 世界の炎症性腸疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Inflammatory Bowel Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…